Cancer
Showing 9951 - 9975 of >10,000
Skin Cancer Trial in Oakland, Golden (Sun Safe Workplaces - Technology, Sun Safe Workplaces -In Person)
Enrolling by invitation
- Skin Cancer
- Sun Safe Workplaces - Technology
- Sun Safe Workplaces -In Person
-
Oakland, California
- +1 more
Oct 18, 2022
Breast Cancer Trial in Boston (CESM, MRI)
Active, not recruiting
- Breast Cancer
- CESM
- MRI
-
Boston, MassachusettsBeth Israel Deaconess
Feb 15, 2022
Chemotherapy Administration on Skeletal Muscle of Breast Cancer
Recruiting
- Breast Cancer
-
Strasbourg, FranceInstitut de Cancerologie Strasbourg Europe
Mar 29, 2022
Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaBiyun Wang, MD
Apr 5, 2023
Metastatic NSCLC (NSCLC), NSCLC Metastatic, NSCLC Stage II Trial in Oldenburg (data collection)
Recruiting
- Metastatic Non-small Cell Lung Cancer (NSCLC)
- +5 more
- data collection
-
Oldenburg, GermanyPius-Hospital
Jul 20, 2022
Siblings, Childhood Cancer, Pediatric Cancer Trial (SibACCESS)
Not yet recruiting
- Siblings
- +3 more
- SibACCESS
- (no location specified)
Jan 14, 2022
HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)
Recruiting
- HER2-negative Breast Cancer
- Advanced Solid Tumor
- ADG106
- +3 more
-
Singapore, SingaporeNational University Hospital
Jun 9, 2022
Hepatocellular Carcinoma, Gastric Cancer Trial in Orange (Nivolumab Injectable Product, Trans-arterial tirapazamine
Recruiting
- Hepatocellular Carcinoma
- Gastric Cancer
- Nivolumab Injectable Product
- Trans-arterial tirapazamine embolization
-
Orange, CaliforniaUniversity of California, Irvine
Apr 13, 2022
Lung Cancer Trial in Winston-Salem (CONNECT Intervention, CONTROL Group)
Completed
- Lung Cancer
- CONNECT Intervention
- CONTROL Group
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Feb 16, 2022
Determine Frequency of DNA-repair Defects in Metastatic Prostate
Completed
- Metastatic Prostate Cancer
- Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis
-
Homewood, Alabama
- +337 more
Jan 17, 2023
Chemo-induced Peripheral Neuropathy Trial (Compression therapy using surgical gloves)
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Compression therapy using surgical gloves
- (no location specified)
Mar 20, 2023
Metastatic Lung Cancer Trial in Lexington (Pathways)
Recruiting
- Metastatic Lung Cancer
- Pathways
-
Lexington, KentuckyUniversity of Kentucky
Jan 13, 2022
Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)
Active, not recruiting
- Castration-Resistant Prostate Cancer
-
Greenville, South Carolina
- +4 more
Aug 2, 2022
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Recruiting
- Tumor, Solid
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Nov 30, 2022
Lung Cancer Trial in Pittsburgh (Sulforaphane, Placebo)
Recruiting
- Lung Cancer
- Sulforaphane
- Placebo
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Dec 6, 2021
Cancer, Nutrition Related Cancer, Malnutrition Trial in Madrid (Flavoured Oral Nutritional Supplement (ONS))
Completed
- Cancer
- +2 more
- Flavoured Oral Nutritional Supplement (ONS)
-
Madrid, SpainBricia Lopez Plaza
Aug 2, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Low Dose Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Oncologic Complications, Quality of Life, Nutrition Poor Trial in Bronx (Dexamethasone, Dronabinol, Mirtazapine)
Terminated
- Oncologic Complications
- +5 more
- Dexamethasone
- +3 more
-
Bronx, New YorkMontefiore Hospital
Mar 23, 2022
Bladder Cancer Trial in Dallas (personalized ultrafractionated stereotactic ablative radiotherapy)
Recruiting
- Bladder Cancer
- personalized ultrafractionated stereotactic ablative radiotherapy
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Feb 24, 2022
The PLATON Network
Recruiting
- Hepatocellular Cancer
- +5 more
-
Frankfurt, Hessen, Germany
- +30 more
Aug 12, 2022
Gastric and Gastroesophageal Junction Adenocarcinoma Trial (Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®))
Not yet recruiting
- Gastric and Gastroesophageal Junction Adenocarcinoma
- Pembrolizumab (Keytruda®), Trifluridine/Tipiracil (Lonsurf®)
- (no location specified)
Aug 17, 2022
Advanced Solid Tumor, NSCLC, Hepatocellular Carcinoma Trial in Canton (CHS-006 (anti-TIGIT), toripalimab (anti-PD-1))
Not yet recruiting
- Advanced Solid Tumor
- +2 more
- CHS-006 (anti-TIGIT)
- toripalimab (anti-PD-1)
-
Canton, OhioGabrail Cancer and Research Center
Feb 23, 2023